FDA Investigates JIA, TNF Blockers, and Cancer in Children
June 4, 2008 by MedHeadlines
Filed under Adolescents, Cancer, Children's Health, Crohn's Disease, Drugs, FDA, Prevention, Rheumatoid Arthritis
The US Food and Drug Administration (FDA) has just announced an investigation into the link between certain drugs known as tumor necrosis factor (TNF) blockers and the development of cancer in children and young adults taking these medications. TNF blockers are routinely prescribed to children aged 18 and younger to treat conditions such as Juvenile Idiopathic Arthritis (JIA), formerly known as Juvenile Rheumatoid Arthritis (JRA), Crohn’s disease, and other diseases of the immune system. Read more
Loading ...
